Interaction Between Aspirin and ACE Inhibitors
- First Online:
- 77 Downloads
Background: Recently, studies have attempted to explore the interaction between ACE inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to reduce mortality in patients with coronary artery disease. Results have been conflicting due, in part, to sub-optimal methods used to explore this interaction.
Methods: We reviewed systematically all studies on mortality in patients treated with ACE inhibitors and aspirin and conducted a meta-analysis in order to explore the interaction between both drugs and resolve discrepancies. To be included, each study had to provide data on mortality of patients who received both drugs, either drug and no drug. These data were necessary to calculate the synergy index (S) and its 95% confidence interval (CI) that we used to quantify the effect due to interaction between ACE inhibitors and aspirin. After testing for heterogeneity of effects, we pooled the S values from the individual studies into one summary measure.
Subsequently, we compared our results with those obtained through the most common but incorrect method of evaluating interaction. This method uses significance testing of the relative risk of mortality when a ‘product term’ between ACE inhibitors and aspirin is entered in a logistic regression model.
Results: Eight studies met the inclusion criteria. The pooled synergy index S indicates slight but precise antagonism between ACE inhibitors and aspirin (S = 0.91; 95% CI 0.80 to 1.03). In contrast, the pooled ‘product term’ is not significant and would have lead to the conclusion of absence of interaction (p = 0.15).
Conclusion: There seems to be an antagonistic interaction between ACE inhibitors and aspirin. Former discrepancies were due to inadequate assessment of interaction. Results from the Studies on Left Ventricular Dysfunction (SOLVD) and Heart Outcome Prevention Evaluation (HOPE) trials that assessed the effect of combined administration of ACE inhibitors and aspirin were not included in this meta-analysis because those trials did not provide enough data to compute the S statistic. It is possible that results from on-going trials such as Women’s Atovarstatin Trial on Cholesterol (WATCH) will shed more light on ACE inhibitor and aspirin interaction in the future.
- 1.The SOLVD investigators. The effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293–302Google Scholar
- 2.The Heart Outcome Prevention Evaluation Study Investigators. Effects of angiotensin converting inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342: 145–53Google Scholar
- 3.Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016–30PubMedCrossRefGoogle Scholar
- 8.Greenland S, Rothman KJ. Concepts of interaction. In: Greenland S, Rothman KJ, editors. Modern epidemiology. 2nd ed. Philadephia: Lippincott-Raven; 1998: 329–42Google Scholar
- 12.Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976; 10: 506–10Google Scholar
- 14.ISIS-4 Fourth International Study of Infarct Survival Collaborative Group — ISIS-4: a randomised factorial trial assessing early oral captopril mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–85Google Scholar
- 16.Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glycerine trinitrate singly and together on six week mortality and ventricular function after myocardial infarction. Lancet 1994; 343: 1115–22Google Scholar
- 17.Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995; 345: 686–7Google Scholar
- 21.The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–8Google Scholar